Catalyst Wire Dossier Catalyst Wire Dossier

SECOX

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SECOX, covering 2020-04-09 to 2020-04-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

See pricing